カテゴリ： 世界, 医療/バイオ, QYResearch

ノロウイルス診断の世界市場2023年：迅速検査キット、PCRキット、ELISAベースキット

■ 英語タイトル：Global Norovirus Diagnostics Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8192）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8192
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：86
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ノロウイルス診断の世界市場2023年：迅速検査キット、PCRキット、ELISAベースキット]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はノロウイルス診断のグローバル市場について調査・分析し、世界のノロウイルス診断市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（迅速検査キット、PCRキット、ELISAベースキット）、用途別セグメント分析（病院、診断ラボ、クリニック）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Abbott、R-Biopharm、ELITechGroup、Danaher Corporation (Cepheid)、Meridian Bioscience、Eiken Chemical、Altona Diagnostics、CerTest Biotec、Elisabeth Pharmacon、Qiagenなどが含まれています。ノロウイルス診断のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ノロウイルス診断市場規模を算出する際に考慮しました。

・ノロウイルス診断市場の概要
- ノロウイルス診断の種類別セグメント
- 世界のノロウイルス診断市場規模：タイプ別分析（迅速検査キット、PCRキット、ELISAベースキット）
- ノロウイルス診断の用途別セグメント
- 世界のノロウイルス診断市場規模：用途別分析（病院、診断ラボ、クリニック）
- 世界のノロウイルス診断市場規模予測（2018年-2029年）

・ノロウイルス診断市場の成長トレンド
- ノロウイルス診断の地域別市場規模（2018年-2029年）
- ノロウイルス診断市場ダイナミクス
- ノロウイルス診断の業界動向
- ノロウイルス診断市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：迅速検査キット、PCRキット、ELISAベースキット
- 世界のノロウイルス診断のタイプ別市場規模（2018年-2023年）
- 世界のノロウイルス診断のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、診断ラボ、クリニック
- 世界のノロウイルス診断の用途別市場規模（2018年-2023年）
- 世界のノロウイルス診断の用途別市場規模（2024年-2029年）

・ノロウイルス診断の地域別市場規模
- 北米のノロウイルス診断市場規模（2018年-2029年）
- 米国のノロウイルス診断市場規模（2018年-2029年）
- ヨーロッパのノロウイルス診断市場規模（2018年-2029年）
- アジア太平洋のノロウイルス診断市場規模（2018年-2029年）
- 中国のノロウイルス診断市場規模（2018年-2029年）
- 日本のノロウイルス診断市場規模（2018年-2029年）
- 韓国のノロウイルス診断市場規模（2018年-2029年）
- インドのノロウイルス診断市場規模（2018年-2029年）
- オーストラリアのノロウイルス診断市場規模（2018年-2029年）
- 中南米のノロウイルス診断市場規模（2018年-2029年）
- 中東・アフリカのノロウイルス診断市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Abbott、R-Biopharm、ELITechGroup、Danaher Corporation (Cepheid)、Meridian Bioscience、Eiken Chemical、Altona Diagnostics、CerTest Biotec、Elisabeth Pharmacon、Qiagen

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Norovirus Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Norovirus Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Norovirus Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Norovirus Diagnostics in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Norovirus Diagnostics include Abbott, R-Biopharm, ELITechGroup, Danaher Corporation (Cepheid), Meridian Bioscience, Eiken Chemical, Altona Diagnostics, CerTest Biotec and Elisabeth Pharmacon, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Norovirus Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Norovirus Diagnostics.
The Norovirus Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Norovirus Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Norovirus Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott
R-Biopharm
ELITechGroup
Danaher Corporation (Cepheid)
Meridian Bioscience
Eiken Chemical
Altona Diagnostics
CerTest Biotec
Elisabeth Pharmacon
Qiagen
Segment by Type
Rapid Test Kits
PCR Kits
ELISA Based Kits
Segment by Application
Hospitals
Diagnostics Labs
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Norovirus Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Norovirus Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Rapid Test Kits
1.2.3 PCR Kits
1.2.4 ELISA Based Kits
1.3 Market by Application
1.3.1 Global Norovirus Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostics Labs
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Norovirus Diagnostics Market Perspective (2018-2029)
2.2 Norovirus Diagnostics Growth Trends by Region
2.2.1 Global Norovirus Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Norovirus Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Norovirus Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Norovirus Diagnostics Market Dynamics
2.3.1 Norovirus Diagnostics Industry Trends
2.3.2 Norovirus Diagnostics Market Drivers
2.3.3 Norovirus Diagnostics Market Challenges
2.3.4 Norovirus Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Norovirus Diagnostics Players by Revenue
3.1.1 Global Top Norovirus Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Norovirus Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Norovirus Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Norovirus Diagnostics Revenue
3.4 Global Norovirus Diagnostics Market Concentration Ratio
3.4.1 Global Norovirus Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Norovirus Diagnostics Revenue in 2022
3.5 Norovirus Diagnostics Key Players Head office and Area Served
3.6 Key Players Norovirus Diagnostics Product Solution and Service
3.7 Date of Enter into Norovirus Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Norovirus Diagnostics Breakdown Data by Type
4.1 Global Norovirus Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Norovirus Diagnostics Forecasted Market Size by Type (2024-2029)
5 Norovirus Diagnostics Breakdown Data by Application
5.1 Global Norovirus Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Norovirus Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Norovirus Diagnostics Market Size (2018-2029)
6.2 North America Norovirus Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Norovirus Diagnostics Market Size by Country (2018-2023)
6.4 North America Norovirus Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Norovirus Diagnostics Market Size (2018-2029)
7.2 Europe Norovirus Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Norovirus Diagnostics Market Size by Country (2018-2023)
7.4 Europe Norovirus Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Norovirus Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Norovirus Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Norovirus Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Norovirus Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Norovirus Diagnostics Market Size (2018-2029)
9.2 Latin America Norovirus Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Norovirus Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Norovirus Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Norovirus Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Norovirus Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Norovirus Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Norovirus Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Norovirus Diagnostics Introduction
11.1.4 Abbott Revenue in Norovirus Diagnostics Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 R-Biopharm
11.2.1 R-Biopharm Company Detail
11.2.2 R-Biopharm Business Overview
11.2.3 R-Biopharm Norovirus Diagnostics Introduction
11.2.4 R-Biopharm Revenue in Norovirus Diagnostics Business (2018-2023)
11.2.5 R-Biopharm Recent Development
11.3 ELITechGroup
11.3.1 ELITechGroup Company Detail
11.3.2 ELITechGroup Business Overview
11.3.3 ELITechGroup Norovirus Diagnostics Introduction
11.3.4 ELITechGroup Revenue in Norovirus Diagnostics Business (2018-2023)
11.3.5 ELITechGroup Recent Development
11.4 Danaher Corporation (Cepheid)
11.4.1 Danaher Corporation (Cepheid) Company Detail
11.4.2 Danaher Corporation (Cepheid) Business Overview
11.4.3 Danaher Corporation (Cepheid) Norovirus Diagnostics Introduction
11.4.4 Danaher Corporation (Cepheid) Revenue in Norovirus Diagnostics Business (2018-2023)
11.4.5 Danaher Corporation (Cepheid) Recent Development
11.5 Meridian Bioscience
11.5.1 Meridian Bioscience Company Detail
11.5.2 Meridian Bioscience Business Overview
11.5.3 Meridian Bioscience Norovirus Diagnostics Introduction
11.5.4 Meridian Bioscience Revenue in Norovirus Diagnostics Business (2018-2023)
11.5.5 Meridian Bioscience Recent Development
11.6 Eiken Chemical
11.6.1 Eiken Chemical Company Detail
11.6.2 Eiken Chemical Business Overview
11.6.3 Eiken Chemical Norovirus Diagnostics Introduction
11.6.4 Eiken Chemical Revenue in Norovirus Diagnostics Business (2018-2023)
11.6.5 Eiken Chemical Recent Development
11.7 Altona Diagnostics
11.7.1 Altona Diagnostics Company Detail
11.7.2 Altona Diagnostics Business Overview
11.7.3 Altona Diagnostics Norovirus Diagnostics Introduction
11.7.4 Altona Diagnostics Revenue in Norovirus Diagnostics Business (2018-2023)
11.7.5 Altona Diagnostics Recent Development
11.8 CerTest Biotec
11.8.1 CerTest Biotec Company Detail
11.8.2 CerTest Biotec Business Overview
11.8.3 CerTest Biotec Norovirus Diagnostics Introduction
11.8.4 CerTest Biotec Revenue in Norovirus Diagnostics Business (2018-2023)
11.8.5 CerTest Biotec Recent Development
11.9 Elisabeth Pharmacon
11.9.1 Elisabeth Pharmacon Company Detail
11.9.2 Elisabeth Pharmacon Business Overview
11.9.3 Elisabeth Pharmacon Norovirus Diagnostics Introduction
11.9.4 Elisabeth Pharmacon Revenue in Norovirus Diagnostics Business (2018-2023)
11.9.5 Elisabeth Pharmacon Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Norovirus Diagnostics Introduction
11.10.4 Qiagen Revenue in Norovirus Diagnostics Business (2018-2023)
11.10.5 Qiagen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Norovirus Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Rapid Test Kits
Table 3. Key Players of PCR Kits
Table 4. Key Players of ELISA Based Kits
Table 5. Global Norovirus Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Norovirus Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Norovirus Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Norovirus Diagnostics Market Share by Region (2018-2023)
Table 9. Global Norovirus Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Norovirus Diagnostics Market Share by Region (2024-2029)
Table 11. Norovirus Diagnostics Market Trends
Table 12. Norovirus Diagnostics Market Drivers
Table 13. Norovirus Diagnostics Market Challenges
Table 14. Norovirus Diagnostics Market Restraints
Table 15. Global Norovirus Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Norovirus Diagnostics Market Share by Players (2018-2023)
Table 17. Global Top Norovirus Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Norovirus Diagnostics as of 2022)
Table 18. Ranking of Global Top Norovirus Diagnostics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Norovirus Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Norovirus Diagnostics Product Solution and Service
Table 22. Date of Enter into Norovirus Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Norovirus Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Norovirus Diagnostics Revenue Market Share by Type (2018-2023)
Table 26. Global Norovirus Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Norovirus Diagnostics Revenue Market Share by Type (2024-2029)
Table 28. Global Norovirus Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Norovirus Diagnostics Revenue Market Share by Application (2018-2023)
Table 30. Global Norovirus Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Norovirus Diagnostics Revenue Market Share by Application (2024-2029)
Table 32. North America Norovirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Norovirus Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Norovirus Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Norovirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Norovirus Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Norovirus Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Norovirus Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Norovirus Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Norovirus Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Norovirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Norovirus Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Norovirus Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Norovirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Norovirus Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Norovirus Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 47. Abbott Company Detail
Table 48. Abbott Business Overview
Table 49. Abbott Norovirus Diagnostics Product
Table 50. Abbott Revenue in Norovirus Diagnostics Business (2018-2023) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. R-Biopharm Company Detail
Table 53. R-Biopharm Business Overview
Table 54. R-Biopharm Norovirus Diagnostics Product
Table 55. R-Biopharm Revenue in Norovirus Diagnostics Business (2018-2023) & (US$ Million)
Table 56. R-Biopharm Recent Development
Table 57. ELITechGroup Company Detail
Table 58. ELITechGroup Business Overview
Table 59. ELITechGroup Norovirus Diagnostics Product
Table 60. ELITechGroup Revenue in Norovirus Diagnostics Business (2018-2023) & (US$ Million)
Table 61. ELITechGroup Recent Development
Table 62. Danaher Corporation (Cepheid) Company Detail
Table 63. Danaher Corporation (Cepheid) Business Overview
Table 64. Danaher Corporation (Cepheid) Norovirus Diagnostics Product
Table 65. Danaher Corporation (Cepheid) Revenue in Norovirus Diagnostics Business (2018-2023) & (US$ Million)
Table 66. Danaher Corporation (Cepheid) Recent Development
Table 67. Meridian Bioscience Company Detail
Table 68. Meridian Bioscience Business Overview
Table 69. Meridian Bioscience Norovirus Diagnostics Product
Table 70. Meridian Bioscience Revenue in Norovirus Diagnostics Business (2018-2023) & (US$ Million)
Table 71. Meridian Bioscience Recent Development
Table 72. Eiken Chemical Company Detail
Table 73. Eiken Chemical Business Overview
Table 74. Eiken Chemical Norovirus Diagnostics Product
Table 75. Eiken Chemical Revenue in Norovirus Diagnostics Business (2018-2023) & (US$ Million)
Table 76. Eiken Chemical Recent Development
Table 77. Altona Diagnostics Company Detail
Table 78. Altona Diagnostics Business Overview
Table 79. Altona Diagnostics Norovirus Diagnostics Product
Table 80. Altona Diagnostics Revenue in Norovirus Diagnostics Business (2018-2023) & (US$ Million)
Table 81. Altona Diagnostics Recent Development
Table 82. CerTest Biotec Company Detail
Table 83. CerTest Biotec Business Overview
Table 84. CerTest Biotec Norovirus Diagnostics Product
Table 85. CerTest Biotec Revenue in Norovirus Diagnostics Business (2018-2023) & (US$ Million)
Table 86. CerTest Biotec Recent Development
Table 87. Elisabeth Pharmacon Company Detail
Table 88. Elisabeth Pharmacon Business Overview
Table 89. Elisabeth Pharmacon Norovirus Diagnostics Product
Table 90. Elisabeth Pharmacon Revenue in Norovirus Diagnostics Business (2018-2023) & (US$ Million)
Table 91. Elisabeth Pharmacon Recent Development
Table 92. Qiagen Company Detail
Table 93. Qiagen Business Overview
Table 94. Qiagen Norovirus Diagnostics Product
Table 95. Qiagen Revenue in Norovirus Diagnostics Business (2018-2023) & (US$ Million)
Table 96. Qiagen Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Norovirus Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Norovirus Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. Rapid Test Kits Features
Figure 4. PCR Kits Features
Figure 5. ELISA Based Kits Features
Figure 6. Global Norovirus Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Norovirus Diagnostics Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Diagnostics Labs Case Studies
Figure 10. Clinics Case Studies
Figure 11. Norovirus Diagnostics Report Years Considered
Figure 12. Global Norovirus Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Norovirus Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Norovirus Diagnostics Market Share by Region: 2022 VS 2029
Figure 15. Global Norovirus Diagnostics Market Share by Players in 2022
Figure 16. Global Top Norovirus Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Norovirus Diagnostics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Norovirus Diagnostics Revenue in 2022
Figure 18. North America Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Norovirus Diagnostics Market Share by Country (2018-2029)
Figure 20. United States Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Norovirus Diagnostics Market Share by Country (2018-2029)
Figure 24. Germany Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Norovirus Diagnostics Market Share by Region (2018-2029)
Figure 32. China Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Norovirus Diagnostics Market Share by Country (2018-2029)
Figure 40. Mexico Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Norovirus Diagnostics Market Share by Country (2018-2029)
Figure 44. Turkey Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Norovirus Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Norovirus Diagnostics Business (2018-2023)
Figure 47. R-Biopharm Revenue Growth Rate in Norovirus Diagnostics Business (2018-2023)
Figure 48. ELITechGroup Revenue Growth Rate in Norovirus Diagnostics Business (2018-2023)
Figure 49. Danaher Corporation (Cepheid) Revenue Growth Rate in Norovirus Diagnostics Business (2018-2023)
Figure 50. Meridian Bioscience Revenue Growth Rate in Norovirus Diagnostics Business (2018-2023)
Figure 51. Eiken Chemical Revenue Growth Rate in Norovirus Diagnostics Business (2018-2023)
Figure 52. Altona Diagnostics Revenue Growth Rate in Norovirus Diagnostics Business (2018-2023)
Figure 53. CerTest Biotec Revenue Growth Rate in Norovirus Diagnostics Business (2018-2023)
Figure 54. Elisabeth Pharmacon Revenue Growth Rate in Norovirus Diagnostics Business (2018-2023)
Figure 55. Qiagen Revenue Growth Rate in Norovirus Diagnostics Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 養殖検査キットのグローバル市場展望 2023年-2029年：ELISAキット、PCRキット、その他
  • 大腸がん分子診断学の世界市場2023年：ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他
  • 循環腫瘍DNA診断の世界市場2023年：検査キット、試薬
  • 間葉系幹細胞/エクソソーム診断/治療の世界市場2023年：タイプⅠ、タイプⅡ
  • ヘリコバクターピロリ非侵襲的検査の世界市場2023年：血清学的検査、尿素呼気検査（UBT）、便潜血検査（SAT）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8192 )"ノロウイルス診断の世界市場2023年：迅速検査キット、PCRキット、ELISAベースキット" (英文：Global Norovirus Diagnostics Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。